Treatment of SCLC cells with an LSD1 inhibitor revealed that sensitivity to this drug could be predicted by the expression levels of members of the MYC family of transcription factors, including MYCL, MYCN, and MYC. The gene discussed is MYCL; the disease is small cell lung carcinoma.